This HTML5 document contains 109 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n11http://dx.doi.org/10.1159/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44205959
rdf:type
wikibase:Item
schema:description
scientific article published in January 2002 2002年學術文章 artikel ilmiah artigo científico บทความทางวิทยาศาสตร์ мақолаи илмӣ научни чланак 2002년 논문 2002年の論文 2002年學術文章 επιστημονικό άρθρο artigo científico article científic vitskapeleg artikkel 2002年学术文章 teaduslik artikkel tieteellinen artikkeli 2002年学术文章 scientific article published in January 2002 bilimsel makale artículo científico publicado en 2002 наукова стаття, опублікована в січні 2002 2002年學術文章 articolo scientifico wissenschaftlicher Artikel научни чланак scienca artikolo vitenskapelig artikkel 2002 nî lūn-bûn 2002年學術文章 bài báo khoa học vetenskaplig artikel научная статья videnskabelig artikel 2002年学术文章 naučni članak artikulong pang-agham 2002年学术文章 scientific article published in January 2002 জানুয়ারি ২০০২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ مقالة علمية نشرت في يناير 2002 tudományos cikk 2002年学术文章 מאמר מדעי 2002年學術文章 2002年学术文章 artigo científico artykuł naukowy article scientifique vědecký článek სამეცნიერო სტატია vedecký článok article scientific научна статия articol științific artikull shkencor artículu científicu espublizáu en 2002 wetenschappelijk artikel
p:P577
wds:Q44205959-6EC285F0-D9F3-462E-B520-A0CBFFDF2E5B
wdt:P577
2002-01-01T00:00:00Z
p:P2093
wds:Q44205959-4E81A56B-F59D-44A4-828A-B0EEBE2B6895 wds:Q44205959-5A0E4874-7601-4FC1-886A-7E0C209CFA41 wds:Q44205959-A09BE0BD-AD91-4E86-B4CC-FFFD705022B4 wds:Q44205959-F6775957-CF17-4469-BF0E-40D939057926 wds:Q44205959-05AFB7CC-56C3-4FCB-B6E7-25B79B3AF7B2 wds:Q44205959-2BDAF78F-4C9D-47F6-B40E-9D301753BF82 wds:Q44205959-2F5B87D2-7CE2-4154-963B-36C14976D49C wds:Q44205959-0802ACB7-1601-46A6-BD0C-9D7D21792A3E wds:Q44205959-2AA62599-DD28-4F9E-979B-8FD37282483F
wdt:P2093
H Gogas G Aravantinos G Stathopoulos N Mylonakis D Bafaloukos G Samonis E Briasoulis D V Skarlos P Kosmidis
rdfs:label
Docetaxel in combination with dacarbazine in patients with advanced melanoma Docetaxel in combination with dacarbazine in patients with advanced melanoma
skos:prefLabel
Docetaxel in combination with dacarbazine in patients with advanced melanoma Docetaxel in combination with dacarbazine in patients with advanced melanoma
schema:name
Docetaxel in combination with dacarbazine in patients with advanced melanoma Docetaxel in combination with dacarbazine in patients with advanced melanoma
p:P50
wds:Q44205959-8295B58C-E659-44B7-A4AA-4F152CA70B7A
wdt:P50
wd:Q56432880
p:P1476
wds:Q44205959-EC416163-1909-4F75-B08F-9F28D001F64D
wdt:P1476
Docetaxel in combination with dacarbazine in patients with advanced melanoma
p:P304
wds:Q44205959-CF11517C-D8A8-45DE-AC5D-AC4851F69F06
wdt:P304
333-337
p:P31
wds:Q44205959-31C021CF-2E0C-40D8-B968-8BA80470A5F0
wdt:P31
wd:Q13442814
p:P921
wds:Q44205959-D670E2F0-534F-4434-876D-33911E46A08E wds:Q44205959-3DE3FBF0-488D-45F5-9D0D-06B7E2A719A9
wdt:P921
wd:Q420436 wd:Q416975
p:P698
wds:Q44205959-EF9362ED-061C-456E-AE83-A50EABAC1229
wdtn:P698
n7:12417787
wdt:P698
12417787
p:P1433
wds:Q44205959-4BC12435-A48C-4CEC-9AB8-0DEE3DA1DAFC
wdt:P1433
wd:Q2016300
p:P433
wds:Q44205959-9A7B5E15-0377-4206-9CD3-7506484B51B6
p:P478
wds:Q44205959-9CFD8083-C5AE-431C-9959-8A1CF6F9D747
wdt:P433
4
wdt:P478
63
p:P356
wds:Q44205959-C8DC1140-B58B-46FE-BE8E-1D348BD070CA
wdtn:P356
n11:000066225
wdt:P356
10.1159/000066225